BillionToOne Financial Ratios
NASDAQ: BLLNHealth CareMedical SpecialitiesUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
BillionToOne ratio analysis
BillionToOne earned a net margin of 2.4% in FY 2025, up from -27.2% a year earlier. Gross margin was 68.3% compared with a median of 38.6% over the prior 2 years. Return on equity reached 1.6%, meaning BillionToOne generated 0.02 dollars of profit for every dollar of shareholders' equity.
Debt-to-equity stood at 0.12, and the current ratio was 11.69. Valuation ratios use the closing share price on each fiscal year-end date and diluted shares from the income statement; profitability and leverage ratios use reported annual figures. Current valuation multiples are on the statistics page.
Summary generated from market data by MetaCap's automated system. Methodology
BillionToOne financial ratios (annual)
| Ratio | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|
| P/E ratio (at fiscal year end) | 637.79 | — | — |
| Price / sales | 4.65 | — | — |
| Price / book | 2.95 | — | — |
| Gross margin | 68.3% | 53.0% | 24.1% |
| Operating margin | 5.3% | -30.9% | -96.9% |
| Net margin | 2.4% | -27.2% | -115.3% |
| Free cash flow margin | 5.2% | -30.7% | -83.4% |
| Return on equity (ROE) | 1.6% | — | — |
| Return on assets (ROA) | 1.2% | -13.8% | — |
| Debt / equity | 0.12 | — | — |
| Current ratio | 11.69 | 8.03 | — |
| Revenue growth | 100.0% | 112.7% | — |